Healthcare: Two Small Biotech Stocks Dreaming Big in Hepatitis C

<div class="x_WordSection1"> <p class="x_MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt; font-family: Calibri, sans-serif; color: rgb(31, 73, 125);">In this week’s healthcare-focused episode of <em>Industry Focus</em>, analysts Michael Douglass and Todd Campbell discuss two small biotechs that recently reported hepatitis C data and look at their opportunity in this large and competitive market.</span></p> </div> <div class="x_WordSection1"> <p class="x_MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt; font-family: Calibri, sans-serif; color: rgb(31, 73, 125);"> </span></p> </div>